Hedge Fund Database

RUBRIC CAPITAL MANAGEMENT LP

Adviser information for RUBRIC CAPITAL MANAGEMENT LP last updated from Form ADV on March 28th, 2024. Select data displayed; additional Form ADV, Form D, Form 13F and other data is available from the Fincoded API.

Advisory Business

Type of Organization Limited Partnership
Fiscal Year End DECEMBER
Legal Location Delaware, United States

Employees

Total Number of Employees 13
Investment Advisory/Research 8
Registered Broker-Dealer Representatives 0
Registered State Investment Advisers 0
Licensed Agents of an Insurance Company 0
No. of Firms/People that Solicit Clients 0

RAUM

Provides Management of Securities Portfolios Yes
Type Accounts RAUM
Discretionary 6 $4.1B
Non-Discretionary 0 $0
Total 6 $4.1B

Clients

Type Number RAUM
Individuals 0 $0
HNW Individuals 0 $0
Banking or thrift institutions 0 $0
Investment companies 0 $0
Business development companies 0 $0
Pooled investment vehicles 6 $4.1B
Pension and profit sharing plans 0 $0
Charitable organizations 0 $0
State or municipal gov entities 0 $0
Other investment advisers 0 $0
Insurance companies 0 $0
Sovereign wealth funds and foreign official institutions 0 $0
Corporations or other businesses 0 $0
Other 0 $0
Type Number
No. of Non-RAUM Clients 0
No. of Non-U.S. Clients 67

Services

Advisory Services Portfolio management for pooled investment vehicles
Compensation % of AUMPerformance-based fees
Other Business Activities Commodity pool operator or commodity trading advisor

Identifiers

SEC RIA File Number 801-108413
SEC ERA File Number 801-108413
SEC CIK Numbers 1687509
SEC CRD Numbers 285090
Legal Entity Identifier 254900LG3FJB8YY8RO55

Principal Office

155 EAST 44TH STREET
SUITE 1630
NEW YORK
NY
United States
Monday - Friday, 9AM - 5.30PM
Tel: 212-418-1888, Fax: None

Websites

www.rubriccapital.com

Chief Compliance Officer

BRIAN KLEINHAUS
155 EAST 44TH STREET
SUITE 1630
NEW YORK
NY
United States
Tel: 212-418-1888
(Full email address available in API data)

Regulatory Contact

MICHAEL NACHMANI
CHIEF OPERATING OFFICER
155 EAST 44TH STREET
SUITE 1630
NEW YORK
NY
United States
Tel: 212-418-1888
(Full email address available in API data)

Industry Affiliates

RUBRIC CAPITAL GP LLC Commodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles

Private Funds

Name Type Assets $USD Min Investment $USD No. Owners
RUBRIC BSR FUND LLC Hedge Fund $196.6M $1.0M 12
RUBRIC CAPITAL MASTER FUND LP Hedge Fund $3,348.4M $1.0M 109

Control Persons

Name Type Entity Title Since Ownership
RUBRIC CAPITAL MANAGEMENT GP LLC Domestic Entity – GENERAL PARTNER 03/2016 < 5%
NACHMANI, CHANAN, MICHAEL Individual – CHIEF OPERATING OFFICER 07/2016 < 5%
ROSEN, DAVID, EFRAIM Individual – LIMITED PARTNER 03/2016 > 75%
ROSEN, DAVID, EFRAIM Individual RUBRIC CAPITAL MANAGEMENT GP LLC MANAGING MEMBER 03/2016 > 75%
KLEINHAUS, BRIAN, WOLF Individual – CHIEF COMPLIANCE OFFICER 03/2018 < 5%
KOSSAKOWSKI, MARGARET Individual – CHIEF FINANCIAL OFFICER 01/2019 < 5%

No. Employees, Historic

20100201920202021202220232024202511 on 4/10/201912 on 3/30/202012 on 9/1/202012 on 3/30/202112 on 3/30/202212 on 5/16/202212 on 8/29/202212 on 3/30/202312 on 6/1/202313 on 3/28/2024

RAUM, Historic

5B3B020192020202120222023202420251507269534 on 4/10/20191587429948 on 3/30/20201587429948 on 9/1/20201931267619 on 3/30/20212509731996 on 3/30/20222509731996 on 5/16/20222509731996 on 8/29/20223993118243 on 3/30/20233993118243 on 6/1/20234125534703 on 3/28/2024

No. Clients, Historic

105020192020202120222023202420254 on 4/10/20194 on 3/30/20204 on 9/1/20205 on 3/30/20215 on 3/30/20225 on 5/16/20225 on 8/29/20226 on 3/30/20236 on 6/1/20236 on 3/28/2024

Holdings

From latest 13F, filed August 13th, 2024 for period ending June 30th, 2024
Name Class Value $USD # Shares Private Fund
AAR CORP COM 42M 575K –
ADAPTIVE BIOTECHNOLOGIES COR COM 51M 14M –
ADEIA INC COM 52M 5M –
ALIGHT INC COM CL A 62M 8M –
AMNEAL PHARMACEUTICALS INC COM STK CL A 68M 11M –
ANI PHARMACEUTICALS INC COM 38M 604K –
ARBUTUS BIOPHARMA CORP COM 5M 2M –
ARCUTIS BIOTHERAPEUTICS INC COM 91M 10M –
ARDELYX INC COM 13M 2M –
ARS PHARMACEUTICALS INC COM 5M 639K –
AVIS BUDGET GROUP COM 72M 690K –
BGC GROUP INC CL A 158M 19M –
BICYCLE THERAPEUTICS PLC SPONSORED ADS 4M 205K –
CANNAE HLDGS INC COM 26M 1M –
CARPENTER TECHNOLOGY CORP COM 15M 140K –
COHERUS BIOSCIENCES INC COM 18M 10M –
COHERUS BIOSCIENCES INC NOTE 1.500% 4/1 2M – –
COLLEGIUM PHARMACEUTICAL INC COM 75M 2M –
CONSTELLIUM SE CL A SHS 69M 4M –
DAVE & BUSTERS ENTMT INC COM 49M 1M –
DOLE PLC ORD SHS 63M 5M –
EXTREME NETWORKS COM 71M 5M –
FLUOR CORP NEW COM 140M 3M –
FTAI INFRASTRUCTURE INC COMMON STOCK 28M 3M –
GOLAR LNG LTD SHS 22M 700K –
GOLAR LNG LTD SHS 205M 7M –
GOODRX HLDGS INC COM CL A 29M 4M –
HERON THERAPEUTICS INC COM 93M 27M –
IMMUNOVANT INC COM 2M 59K –
JAZZ PHARMACEUTICALS PLC SHS USD 66M 617K –
KINIKSA PHARMACEUTICALS INTL ORD SHS CL A 45M 2M –
KOPPERS HOLDINGS INC COM 13M 361K –
LIBERTY GLOBAL LTD COM CL A 96M 6M –
LIBERTY GLOBAL LTD COM CL C 63M 4M –
MATIV HOLDINGS INC COM 68M 4M –
MEREO BIOPHARMA GROUP PLC SPON ADS 55M 15M –
MR COOPER GROUP INC COM 123M 2M –
NCR VOYIX CORPORATION COM 42M 3M –
OMNIAB INC COM 11M 3M –
OPKO HEALTH INC COM 56M 44M –
ORTHOFIX MED INC COM 49M 4M –
OVID THERAPEUTICS INC COM 4M 5M –
PACTIV EVERGREEN INC COM 65M 6M –
PEDIATRIX MEDICAL GROUP INC COM 62M 8M –
PLAYA HOTELS & RESORTS NV SHS 9M 1M –
PLAYSTUDIOS INC CLASS A COM 6M 3M –
PROTAGONIST THERAPEUTICS INC COM 7M 198K –
QUIDELORTHO CORP COM 121M 4M –
RENEW ENERGY GLOBAL PLC CL A SHS 84M 14M –
REVANCE THERAPEUTICS INC COM 7M 3M –
RISKIFIED LTD SHS CL A 27M 4M –
ROIVANT SCIENCES LTD SHS 243M 23M –
SCHRODINGER INC COM 61M 3M –
SCPHARMACEUTICALS INC COM 15M 4M –
SHUTTERSTOCK INC COM 15M 382K –
STRATASYS LTD SHS 50M 6M –
TELADOC HEALTH INC COM 45M 5M –
TELESAT CORP CL A & CL B SHS 9M 960K –
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS 281M 17M –
THERAPEUTICSMD INC COM NEW 2M 1M –
TRANSALTA CORP COM 33M 5M –
TREVI THERAPEUTICS INC COM 15M 5M –
VIATRIS INC COM 214M 20M –
VINCERX PHARMA INC COM NEW 95K 117K –
VISTRA CORP COM 114M 1M –
WEREWOLF THERAPEUTICS INC COM 3M 1M –
XPERI INC COMMON STOCK 34M 4M –
ZYMEWORKS INC COM 33M 4M –